Bayer Helps Victims Of Earthquake In Haiti

Following the devastating earthquake in Haiti, Bayer is providing immediate relief in the form of medicines worth around EUR 90,000. The company will make the medicines available to the Red Cross in the Dominican Republic to enable it to be distributed quickly from there to neighboring country Haiti.

Efficacy Of Flu Vaccine Drastically Reduced For RA Patients Treated With Rituximab

Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6 – 10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment. Previous influenza vaccination in rituximab-treated patients does increase pre- and post-vaccination titers, providing [...]

‘Chemofog’ Takes Toll On Cancer Patients, Australia

A condition that affects the memory and concentration of cancer patients undergoing chemotherapy is sustained in a subgroup of patients, compromising their ability to function and long-term quality of life, according to research presented on wednesday at a major cancer conference.

Sleep Deprivation Can Negatively Affect Information Processing

A study in the Nov.1 issue of the journal Sleep shows that sleep deprivation causes some people to shift from a more automatic, implicit process of information categorization (information-integration) to a more controlled, explicit process (rule-based). This use of rule-based strategies in a task in which information-integration strategies are optimal can lead to potentially devastating [...]

FDA Approves Donor Screening Test For Antibodies To HIV

The U.S. Food and Drug Administration announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System.